Drug
GS 9411
GS 9411: highest development phase Phase 1, developed by Gilead Sciences. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Gilead Sciences
Trials
| Drug | Phase | Indication |
|---|---|---|
| GS-9411 NCT01025713 | Phase 1 | Cystic Fibrosis |
Latest
No recent events.
Follow GS 9411 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.